Renate Parry - Jun 4, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Renate Parry
Stock symbol
GYRE
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:22 PM
Previous filing
Aug 16, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Parry Renate Director C/O GYRE THERAPEUTICS, INC., 12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO /s/ Ruoyu Chen, as attorney-in-fact for Renate Parry 2025-06-06 0001982817

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +26K $0.00 26K Jun 4, 2025 Common Stock 26K $8.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.